1154 results
Thumbnail

D1.25 - Clinical Characteristics of Chronic Urticaria in Adults Under 45 Years Old with Vitamin D Insufficiency

Thumbnail

D1.259 - Healthcare interoperability: the promises and pitfalls relating to penicillin allergy delabelling

Thumbnail

D1.264 - Assessment by general practitioners of a therapeutic patient education guide for allergic patients

Thumbnail

D1.274 - Anaphylaxis Risks in Beekeeping: The Importance of Developing a Health Education Program

Thumbnail

D1.284 - Trends in Recurrent Anaphylaxis Triggered by Food, Drug, and Insect Allergies from 2015 to 2021: A Population-Based Retrospective Cohort Study Using the National Insurance Claims Database of Japan

Thumbnail

D1.293 - Urinary Levels of Environmental Pollutants Are Associated with the Severity and Persistence of Atopic Dermatitis in Young Children

Thumbnail

D1.296 - Paediatric AD vs Food Allergy Management in the South of Ireland

Thumbnail

D1.297 - The Effects of Virtual Reality on AD

Thumbnail

D1.299 - The prevalence and management features of adolescents with atopic dermatitis under humanitarian crisis

Thumbnail

D1.302 - The Fecal Microbiome: Geographical Location and Associated Dietary Habits Matter More Than Atopic Dermatitis

Thumbnail

D1.309 - Association of Antenatal Corticosteroids with Risk of Autoimmune Diseases in Children: a Nationwide Cohort Study

Thumbnail

D1.342 - Therapeutic Potential of LCAA-PSF in Atopic Dermatitis: Insights from an MC903-Induced Mouse Model

Thumbnail

D1.349 - Age-related fungal molecular clusters revealed by allergen chip assay in Eastern France

Thumbnail

D1.352 - Assessment of the Efficacy of Mepolizumab in Modulating Disease Activity in Eosinophilic Granulomatosis with Polyangiitis: A 12-Month Analysis Evaluating the Birmingham Vasculitis Activity Score

Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.372 - Potential blood biomarkers of disease activity in patients with chronic spontaneous urticaria

Thumbnail

D1.375 - Ciclosporin for omalizumab-refractory CSU in a Paediatric population in Cork University Hospital: a case series

Thumbnail

D1.376 - Emerging inmunomodulatory agents for atopic dermatitis

Thumbnail

D1.377 - Berotralstat effectively controls a type 2 Hereditary Angioedema patient, refractory to other long-term prophylaxis treatments – Case report

Thumbnail

D1.378 - Evaluating the efficacy of dupilumab treatment for atopic dermatitis across geographic areas: A systematic review and meta-regression analysis